BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33252065)

  • 1. Comparison of contrast-enhanced ultrasound targeted biopsies versus standard systematic biopsies for prostate cancer correction in different PSA value groups in rural China.
    Lu DY; Liu L; Shen L; Cai JR; Xu L; Xiang LH
    Clin Hemorheol Microcirc; 2021; 77(3):295-301. PubMed ID: 33252065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of contrast-enhanced ultrasound targeted biopsy versus standard systematic biopsy for clinically significant prostate cancer detection: results of a prospective cohort study with 1024 patients.
    Yunkai Z; Yaqing C; Jun J; Tingyue Q; Weiyong L; Yuehong Q; Wenbin G; Lifeng W; Jun Q
    World J Urol; 2019 May; 37(5):805-811. PubMed ID: 30187133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of power doppler and ultrasound contrast agents in early imaging-based diagnosis of organ-confined prostate cancer: Is it possible to spare cores with contrast-guided biopsy?
    Delgado Oliva F; Arlandis Guzman S; Bonillo García M; Broseta Rico E; Boronat Tormo F
    Eur J Radiol; 2016 Oct; 85(10):1778-1785. PubMed ID: 27666616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients.
    Postema AW; Scheltema MJ; Mannaerts CK; Van Sloun RJ; Idzenga T; Mischi M; Engelbrecht MR; De la Rosette JJ; Wijkstra H
    BMC Urol; 2017 Apr; 17(1):27. PubMed ID: 28381220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of prostate volume on prostate cancer detection using a combined approach of contrast-enhanced ultrasonography-targeted and systematic grey-scale biopsy.
    Colleselli D; Bektic J; Schaefer G; Frauscher F; Mitterberger M; Brunner A; Schwentner C; Bartsch G; Horninger W; Pelzer AE
    BJU Int; 2007 Dec; 100(6):1264-7. PubMed ID: 17850369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate: an original technique with a good cancer detection rate.
    Wang L; Wang X; Zhao W; Zhao Z; Li Z; Fei S; Zhu H; Ji X; Yang B; Li N; Na Y
    BMC Urol; 2019 Nov; 19(1):107. PubMed ID: 31684917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
    Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
    Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound evaluation of the prostate before transrectal ultrasound-guided biopsy can improve diagnostic sensitivity: A STARD-compliant article.
    Liu G; Wu S; Huang L
    Medicine (Baltimore); 2020 May; 99(19):e19946. PubMed ID: 32384441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies.
    Maxeiner A; Nest AM; Stephan C; Cash H; Baur ADJ; Fischer T; Kilic E; Piper SK; Nowak CP; Busch J; Miller K; Mang J
    Urol Int; 2020; 104(3-4):205-213. PubMed ID: 31801153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy.
    Chang CH; Chiu HC; Lin WC; Ho TL; Chang H; Chang YH; Huang CP; Wu HC; Yang CR; Hsieh PF
    Biomed Res Int; 2017; 2017():7617148. PubMed ID: 29159180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Parameters Identifying Men Eligible for a Sole MRI/Ultrasound Fusion-Guided Targeted Biopsy without an Additional Systematic Biopsy.
    Günzel K; Haas M; Maxeiner A; Stephan C; Buckendahl J; Asbach P; Miller K; Kempkensteffen C; Cash H
    Urol Int; 2017; 98(1):15-21. PubMed ID: 27618633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional Targeted Biopsy in Clinically Suspected Prostate Cancer: Prospective Randomized Comparison between Contrast-Enhanced Ultrasound and Sonoelastography Guidance.
    Koh J; Jung DC; Oh YT; Yoo MG; Noh S; Han KH; Rha KH; Choi YD; Hong SJ
    Ultrasound Med Biol; 2015 Nov; 41(11):2836-41. PubMed ID: 26298036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can fewer transperineal systematic biopsy cores have the same prostate cancer detection rate as of magnetic resonance imaging/ultrasound fusion biopsy?
    Liu H; Ruan M; Wang H; Wang H; Li X; Song G
    Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):589-595. PubMed ID: 32719353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
    Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
    BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
    Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
    Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain Elastography-Targeted Biopsy: Does Prostate Volume Affect Prostate Cancer Detection?
    Zhu YC; Shan J; Zhang Y; Jiang Q; Wang YB; Deng SH; Qu QH; Li Q
    Med Sci Monit; 2019 Nov; 25():8836-8842. PubMed ID: 31754091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat Targeted Prostate Biopsy under Guidance of Multiparametric MRI-Correlated Real-Time Contrast-Enhanced Ultrasound for Patients with Previous Negative Biopsy and Elevated Prostate-Specific Antigen: A Prospective Study.
    Jang DR; Jung DC; Oh YT; Noh S; Han K; Kim K; Rha KH; Choi YD; Hong SJ
    PLoS One; 2015; 10(6):e0130671. PubMed ID: 26083348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of contrast-enhanced ultrasonography in the diagnosis of prostate cancer in patients with different PSA concentrations].
    Lu DY; Shen L; Cai JR; Chen YH; Xu L; Liu L
    Zhonghua Nan Ke Xue; 2018 Janurary; 24(1):50-54. PubMed ID: 30157360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound targeted versus conventional ultrasound guided systematic prostate biopsy for the accurate diagnosis of prostate cancer: A meta-analysis.
    Zhang M; Meng Q; Feng L; Wang D; Qu C; Tian H; Jia J; Gao Q; Wang X
    Medicine (Baltimore); 2022 Dec; 101(51):e32404. PubMed ID: 36595877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of MRI/ultrasound fusion in primary biopsy for the diagnosis of prostate cancer].
    Distler F; Radtke JP; Kesch C; Roethke M; Schlemmer HP; Roth W; Hohenfellner M; Hadaschik B
    Urologe A; 2016 Feb; 55(2):146-55. PubMed ID: 26556268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.